<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T02:13:32Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/176455" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/176455</identifier><datestamp>2025-12-04T19:22:35Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478858</setSpec><setSpec>col_2072_478917</setSpec><setSpec>col_2072_478921</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Ventilator-Associated Pneumonia and PaO(2)/F(I)O(2) Diagnostic Accuracy: Changing the Paradigm?</dc:title>
   <dc:creator>Ferrer Monreal, Miquel</dc:creator>
   <dc:creator>Sequeira, Telma</dc:creator>
   <dc:creator>Cillóniz, Catia</dc:creator>
   <dc:creator>Dominedò, Cristina</dc:creator>
   <dc:creator>Bassi, Gianluigi Li</dc:creator>
   <dc:creator>Martín Loeches, Ignacio</dc:creator>
   <dc:creator>Torres Martí, Antoni</dc:creator>
   <dc:subject>Pneumologia</dc:subject>
   <dc:subject>Unitats de cures intensives</dc:subject>
   <dc:subject>Infeccions nosocomials</dc:subject>
   <dc:subject>Pneumology</dc:subject>
   <dc:subject>Intensive care units</dc:subject>
   <dc:subject>Nosocomial infections</dc:subject>
   <dc:description>Background: Ventilator-associated pneumonia (VAP) is associated to longer stay and poor outcomes. Lacking definitive diagnostic criteria, worsening gas exchange assessed by PaO2/FIO2 ≤ 240 in mmHg has been proposed as one of the diagnostic criteria for VAP. We aim to assess the adequacy of PaO2/FIO2 ≤ 240 to diagnose VAP. Methods: Prospective observational study in 255 consecutive patients with suspected VAP, clustered according to PaO2/FIO2 ≤ 240 vs. > 240 at pneumonia onset. The primary analysis was the association between PaO2/FIO2 ≤ 240 and quantitative microbiologic confirmation of pneumonia, the most reliable diagnostic gold-standard. Results: Mean PaO2/FIO2 at VAP onset was 195 ± 82; 171 (67%) cases had PaO2/FIO2 ≤ 240. Patients with PaO2/FIO2 ≤ 240 had a lower APACHE-II score at ICU admission; however, at pneumonia onset they had higher CPIS, SOFA score, acute respiratory distress syndrome criteria and incidence of shock, and less microbiological confirmation of pneumonia (117, 69% vs. 71, 85%, p = 0.008), compared to patients with PaO2/FIO2 > 240. In multivariate logistic regression, PaO2/FIO2 ≤ 240 was independently associated with less microbiological confirmation (adjusted odds-ratio 0.37, 95% confidence interval 0.15-0.89, p = 0.027). The association between PaO2/FIO2 and microbiological confirmation of VAP was poor, with an area under the ROC curve 0.645. Initial non-response to treatment and length of stay were similar between both groups, while hospital mortality was higher in patients with PaO2/FIO2 ≤ 240. Conclusion: Adding PaO2/FIO2 ratio ≤ 240 to the clinical and radiographic criteria does not help in the diagnosis of VAP. PaO2/FIO2 ratio > 240 does not exclude this infection. Using this threshold may underestimate the incidence of VAP.</dc:description>
   <dc:date>2021-04-19T11:24:01Z</dc:date>
   <dc:date>2021-04-19T11:24:01Z</dc:date>
   <dc:date>2019-08-14</dc:date>
   <dc:date>2021-04-19T11:24:01Z</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>2077-0383</dc:identifier>
   <dc:identifier>https://hdl.handle.net/2445/176455</dc:identifier>
   <dc:identifier>698283</dc:identifier>
   <dc:identifier>31416285</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Reproducció del document publicat a: https://doi.org/10.3390/jcm8081217</dc:relation>
   <dc:relation>Journal of Clinical Medicine, 2019, vol. 8, num. 8</dc:relation>
   <dc:relation>https://doi.org/10.3390/jcm8081217</dc:relation>
   <dc:rights>cc-by (c) Ferrer Monreal, Miquel et al., 2019</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/3.0/es</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>13 p.</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>MDPI</dc:publisher>
   <dc:source>Articles publicats en revistes (Medicina)</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>